Wisconsin Endocrine Society Meeting 2018
This program will address the subject of X-Linked Hypophosphatemia with an overview of the latest pathophysiology and mechanisms involved with this disorder along with possible treatment options. This is a very important topic in Endocrine bone disorders and this program will provide new information and update practitioners on this disorder. New information is always being gained and applied in novel ways. Even for the expert practitioners, it is a challenge to stay abreast of the latest information and intrepretation of findings and data. In both an academic and private practice setting, updates on any new endocrine topics are always welcome.
- Understand the bone remodeling cycle;
- and apply that knowledge to explain the mechanism of action and evaluate the efficacy of drugs used to treat low bone mass.
- Be able to explain how the new biology of bone will help devise better therapies for bone loss including such problems as bone loss with long-term space travel.
5:30 - 6:30 PM Registration and Cocktails
6:30 - 7:30 PM Dinner
7:00 - 8:00 PM "Basic Bone Biology: Bewildering Babble from a Bombastic Bonehead or Really Relevant?" presented by Dr. Karl Insogna
8:00 - 8:30 PM Q & A and Closing Meeting
All persons in control of content have NO relevant financial relationships with the exception of:
|Roger Kulstad, MD||Navitus Pharmacy and Therapeutics Committee||Consultant|
|Karl Insogna, MD||Ultragenyx||PI for Clinical Trial|
|Karl Insogna, MD||Ultragenyx||Scientific Advisory Board|
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and The Wisconsin Endocrine Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
Registration Fee = $35.00
Please note! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover.
A $2.50 non-refundable processing fee is assessed on all registrations.
Cancellation policy: No refunds